Browse the evidence

Higher saturated fat intake was associated with lower risk of stroke (HR 0.79).

Higher saturated fat intake may be protective against stroke.

Resting metabolic rate is not reduced in hypocretin-deficient narcoleptic men (1766 +/- 227 kcal/24h).

Narcoleptic patients do not have a lower resting metabolic rate, which may influence obesity considerations.

There were no significant differences in the VO2peak values reached in either PSP or PIP protocol (64.4 +/- 5.9 vs 66.5 +/- 6.0 mLO2 x kg(-1) x min(-1)).

Both treadmill protocols can be used interchangeably for measuring VO2peak in these athletic populations.

The glycemic index values of individual foods do not predict glycemic response to mixed meals.

Practitioners should be cautious in using glycemic index as a predictor for mixed meal responses.

The observed glycemic response did not differ between diets.

Dietary variations may not significantly impact glycemic responses in healthy individuals.

Genetics do not significantly contribute to the causes of obesity as per the available data.

Focus on environmental factors rather than genetic predispositions in obesity prevention strategies.

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is projected to increase from 33.7% (86.3 million people) in 2020 to 41.4% (121.9 million people) by 2050.

Health systems should prepare for a significant increase in MASLD cases.

Cases of metabolic dysfunction-associated steatohepatitis (MASH) are expected to rise from 14.9 million (5.8% of US adults) in 2020 to 23.2 million (7.9% of US adults) by 2050.

Increased awareness and management strategies for MASH are needed.

Liver-related mortality is estimated to increase from 30,500 deaths (1.0% of all-cause deaths in adults) in 2020 to 95,300 deaths (2.4%) in 2050.

Strategies to reduce liver-related mortality must be prioritized.

The dietary treatments did not alter weight, body fat, or lipid profile of the subjects.

Athletes can adopt a high-fat diet without concerns about negative impacts on body composition.

Plasma TMAO and related metabolites were not significantly associated with type 2 diabetes risk.

The findings suggest that TMAO and related metabolites may not be useful biomarkers for predicting type 2 diabetes risk.

Two weeks of traditional exercise recommendations (TER) did not improve metabolic functioning in sedentary obese men.

Traditional exercise recommendations may not lead to metabolic improvements in sedentary obese individuals.

No changes in fasting plasma glucose, insulin, non-esterified fatty acids (NEFA), homeostasis model assessment of insulin sensitivity (HOMA-IR), body composition, and VO(2peak) were observed after training.

Short-term exercise does not lead to changes in key metabolic markers in sedentary obese individuals.

There were no between-group differences in body composition and adaptive thermogenesis.

Practitioners should note that both diets did not significantly affect body composition or thermogenesis.

The obesity paradox was not observed among those with coronary heart disease (CHD), with an adjusted hazard ratio of 1.00 (95% CI 0.86, 1.17).

Clinicians should be cautious in applying the obesity paradox to patients with coronary heart disease.

In the intensive lifestyle intervention group, higher variability of BMI is not associated with increased risks of all-cause mortality, cardiovascular deaths, or cardiovascular events.

Intensive lifestyle interventions may mitigate the risks associated with BMI variability in patients with type 2 diabetes.

There were no significant changes in HbA1c between year 1 and year 4 for all bMVPA timing groups.

Practitioners should be aware that initial improvements in glycemic control may not persist long-term.

There was no significant change in hepatic insulin sensitivity after 6 weeks of rifaximin treatment (35.2 [15.3-51.7]% vs. 30.0 [10.8-50.5]%, P = 0.47).

Rifaximin does not appear to enhance insulin sensitivity in NASH patients.

Prolonged calorie restriction has been shown to extend both the median and maximal lifespan in a variety of lower species.

Calorie restriction may be a viable strategy for extending lifespan, though this is primarily observed in non-human species.

Endoscopic hydrothermal duodenal mucosal resurfacing is well tolerated in human subjects.

Practitioners can consider this procedure as a safe option for patients.

Endoscopic hydrothermal duodenal mucosal resurfacing has an acceptable safety profile.

This procedure can be considered for patients with a focus on safety.

Biliopancreatic diversion (BPD) and mini gastric bypass (mini-GBP) have the highest diabetes remission rates among the surgical treatments analyzed.

Clinicians should consider BPD and mini-GBP as effective options for achieving diabetes remission in patients.

Sleeve gastrectomy has emerged as the most popular bariatric procedure in the last 10 years.

Surgeons should be aware that sleeve gastrectomy is currently the preferred option among patients.

Basal metabolic rate adjusted for body composition changes with gestational weight gain was not significantly different between high gainers and low+ideal gainers (151±33 compared with 129±36 kcal per day; P=.66).

Practitioners should note that increased weight gain does not necessarily correlate with increased basal metabolic rate when adjusted for body composition.